Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

20%

1 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
1(33.3%)
Phase 2
1(33.3%)
Phase 3
1(33.3%)
3Total
N/A(1)
Phase 2(1)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT04054453Not ApplicableUnknown

Prevention of Epilepsy by Reducing Neonatal Encephalopathy

Role: collaborator

NCT01278719Unknown

The Factors Associated With the Formation of Nasal polyp-a Case Control and Descriptive Study

Role: lead

NCT00966056Phase 2Completed

Study of Mitomycin C and Nasal Splint to Treat Nasal Synechiae

Role: lead

NCT00270660Unknown

A Study of the Clinicopathologic Behaviour of the Different Types of Unsafe Chronic Otitis Media

Role: lead

NCT00271778Phase 3Unknown

A Comparative Study of the Outcomes of 2 Surgical Procedures for Safe Type of Chronic Otitis Media

Role: lead

All 5 trials loaded